Qiagen, NeoGenomics to offer companion diagnostics for cancer patients
Qiagen and NeoGenomics have signed an agreement to speed up the availability of companion diagnostics that allow precision…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
03 Dec 18
Qiagen and NeoGenomics have signed an agreement to speed up the availability of companion diagnostics that allow precision…
28 Nov 18
Quest Diagnostics has agreed to acquire the clinical laboratory services business of Boyce and Bynum Pathology Laboratories (BBPL),…
28 Nov 18
Molecular diagnostic firm Mesa Biotech has secured 510(k) clearance from the US Food and Drug Administration (FDA) for…
27 Nov 18
LGC, which owned by funds affiliated with global investment firm KKR. has acquired SeraCare Life Sciences to strengthen…
23 Nov 18
Multinational healthcare firm Roche has introduced FoundationOne CDx genomic profiling assay in Singapore to guide personalized treatment decisions.
23 Nov 18
Cellanyx and clinical collaborators have reported results of a prostate cancer clinical study demonstrating the ability of the…
23 Nov 18
Genomic Vision (GV) has entered into a licensing agreement with Phyteneo for the commercialization of the HPV integration…
20 Nov 18
US-based biotechnology firm Invivoscribe has submitted LeukoStrat CDx FLT3 mutation assay to the Pharmaceuticals and Medical Devices Agency…
20 Nov 18
Two Pore Guys, a developer of single molecule biosensors for diagnostic uses, has received a $2.8m grant from…
19 Nov 18
Mobidiag has secured the final tranche €4m tranche of a €15m three-year project secured from the European Investment…